These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 21465678

  • 1. Lung function changes in asthmatic children treated with HFA-BDP.
    Eid N, Morton R.
    Pediatr Pulmonol; 2011 Sep; 46(9):837-41. PubMed ID: 21465678
    [Abstract] [Full Text] [Related]

  • 2. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
    Barnes N, Price D, Colice G, Chisholm A, Dorinsky P, Hillyer EV, Burden A, Lee AJ, Martin RJ, Roche N, von Ziegenweidt J, Israel E.
    Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
    [Abstract] [Full Text] [Related]

  • 3. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [Abstract] [Full Text] [Related]

  • 4. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 5. Improved control of asthma symptoms with a reduced dose of HFA-BDP extrafine aerosol: an open-label, randomised study.
    Ederle K, Multicentre Study Group.
    Eur Rev Med Pharmacol Sci; 2003 May; 7(2):45-55. PubMed ID: 12911119
    [Abstract] [Full Text] [Related]

  • 6. Comparative improvement of asthma symptoms and expiratory flows after corticosteroid treatment: a method to assess the effect of corticosteroids on large vs. small airways?
    Boulet LP.
    Respir Med; 2006 Mar; 100(3):496-502. PubMed ID: 16039107
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [Abstract] [Full Text] [Related]

  • 8. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.
    Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.
    J Aerosol Med; 2002 Dec; 15(4):407-14. PubMed ID: 12581507
    [Abstract] [Full Text] [Related]

  • 9. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children].
    Yoshida Y, Inoue T, Nishikido T, Kameda M, Takamatu I, Doi S.
    Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554
    [Abstract] [Full Text] [Related]

  • 10. Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma.
    Nicolini G, Chetta A, Simonazzi A, Tzani P, Aiello M, Olivieri D.
    Allergy Asthma Proc; 2010 Dec; 31(5):85-90. PubMed ID: 20929599
    [Abstract] [Full Text] [Related]

  • 11. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
    Wolthers OD, Walters EG.
    Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529
    [Abstract] [Full Text] [Related]

  • 12. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
    Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
    Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
    [Abstract] [Full Text] [Related]

  • 13. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography.
    Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW, Simmons MD, Suttorp M, Colice GL, Vanden Burgt JA, Aberle DR.
    J Allergy Clin Immunol; 1999 Dec; 104(6):S258-67. PubMed ID: 10588987
    [Abstract] [Full Text] [Related]

  • 16. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J, Cantini L.
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [Abstract] [Full Text] [Related]

  • 17. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
    Magnussen H.
    Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
    [Abstract] [Full Text] [Related]

  • 18. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
    Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
    Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.